Is CERC or DVY a better dividend investment in 2026?

CERC currently yields 68.26% with a 5% 5-year dividend growth rate. DVY yields 3.50% with 5% growth. The better choice depends on your goal: CERC offers higher current income.

What is the dividend yield difference between CERC and DVY?

CERC has a forward dividend yield of 68.26% ($2.00/share annually). DVY yields 3.50% ($5.25/share annually). The yield gap is 64.76 percentage points.

Home › Compare › CERC vs DVY

CERC vs DVY: Dividend Comparison 2026

CERC yields 68.26% · DVY yields 3.50%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CERC wins by $943.8K in total portfolio value

INVESTMENT

TIME HORIZON10 years

CERC

● Live price

68.26%

Share price

$2.93

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$968.9K

Annual income

$249,593.79

Full CERC calculator →

DVY

● Live price

3.50%

Share price

$150.03

Annual div

$5.25

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.1K

Annual income

$437.78

Full DVY calculator →

Portfolio growth — CERC vs DVY

📍 CERC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CERC	DVY
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CERC + DVY cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CERC pays

DVY pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CERC

Annual income on $10K today (after 15% tax)

$5,802.05/yr

After 10yr DRIP, annual income (after tax)

$212,154.72/yr

DVY

Annual income on $10K today (after 15% tax)

$297.17/yr

After 10yr DRIP, annual income (after tax)

$372.11/yr

At 15% tax rate, CERC beats the other by $211,782.61/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CERC + DVY for your $10,000?

CERC: 50%DVY: 50%

100% DVY50/50100% CERC

Portfolio after 10yr

$497.0K

Annual income

$125,015.78/yr

Blended yield

25.16%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on CERC right now

CERC

Analyst Ratings

Buy

Hold

Consensus: Buy

DVY

No analyst data

Altman Z

307.5

Piotroski

1/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CERC buys

DVY buys

No recent congressional trades found for CERC or DVY in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCERCDVY

Forward yield	68.26% ✓	3.50%
Annual dividend / share	$2.00	$5.25 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$968.9K ✓	$25.1K
Annual income after 10y	$249,593.79 ✓	$437.78
Total dividends collected	$822.0K ✓	$4.0K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: CERC vs DVY ($10,000, DRIP)

Year	CERC Portfolio	CERC Income/yr	DVY Portfolio	DVY Income/yr	Gap
1← crossover	$17,526	$6,825.94	$11,050	$349.62	+$6.5K → CERC
2	$29,933	$11,180.47	$12,184	$361.04	+$17.7K → CERC
3	$49,875	$17,846.30	$13,409	$372.07	+$36.5K → CERC
4	$81,156	$27,790.26	$14,730	$382.68	+$66.4K → CERC
5	$129,099	$42,261.97	$16,154	$392.89	+$112.9K → CERC
6	$200,966	$62,830.03	$17,688	$402.69	+$183.3K → CERC
7	$306,442	$91,407.71	$19,338	$412.07	+$287.1K → CERC
8	$458,156	$130,263.77	$21,113	$421.04	+$437.0K → CERC
9	$672,242	$182,014.41	$23,020	$429.61	+$649.2K → CERC
10	$968,892	$249,593.79	$25,070	$437.78	+$943.8K → CERC

CERC vs DVY: Complete Analysis 2026

CERC — Stock

Cerecor Inc., a biopharmaceutical company, focuses on development and commercialization of treatments for rare pediatric and orphan diseases. It develop therapies for the treatment of inherited metabolic disorders, such as CERC-801 and CERC-802, which completed the phase I clinical trial; and CERC-803. The company is also involved in the developing of CERC-007, an anti-IL-18 monoclonal antibody for the treatment of autoimmune inflammatory diseases, such as adult onset stills disease and multiple myeloma; CERC-006, a dual mTOR inhibitor to treat complex lymphatic malformations; and CERC-002, an anti-LIGHT monoclonal antibody for the treatment of Pediatric-onset Crohn's diseases. In addition, it develops CERC-913, a protide nucleotide for the treatment of mitochondrial disorder; CERC-005, a monoclonal antibody to treat rare auto-inflammatory diseases; CERC-301 for the treatment of symptomatic Orthostatic Hypotension; and CERC-406 for the treatment of Parkinson's disease. Further, the company offers Millipred, an oral prednisolone for the treatment of inflammatory conditions, such as arthritis, blood disorders, immune system disorders, skin and eye conditions, respiratory disorders, cancer, and severe allergies. The company was formerly known as Ceregen Corporation and changed its name to Cerecor Inc. in March 2011. Cerecor Inc. was founded in 2011 and is headquartered in Rockville, Maryland.

Full CERC Calculator →

DVY — ETF

The iShares Select Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full DVY Calculator →

📬

Get this CERC vs DVY comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CERC vs SCHD CERC vs JEPI CERC vs O CERC vs KO CERC vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.